4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-065833
Chief Medical Officer sold 5,000 shares at an average $35.85 ($179,255)
- Chief Medical Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2021-11-17 | Option exercise | +5,000 | $5.18 | $25,875 | 105,277 | D |
| Pang Phillip Chief Medical Officer | 2021-11-17 | Sale | −4,535 | $35.75 | $162,143 | 100,742 | D |
| Pang Phillip Chief Medical Officer | 2021-11-17 | Sale | −465 | $36.80 | $17,112 | 100,277 | D |
| Derivatives | |||||||
| Pang Phillip Chief Medical Officer | 2021-11-17 | Option exercise · Stock Option (Right to Buy) | −5,000 | 42,129 | D | ||
| Open-market sales · 5,000 sh · avg $35.85 · $179,255 | |||||||
Loading xslF345X03/doc4.xml…